摘要
阿尔茨海默氏病(AD)老年痴呆症的命名障碍与左颞叶前部萎缩相关(ATL)。我们的目的是阐明是否左前颞叶的局部脑葡萄糖代谢(作为突触功能障碍和神经退行性疾病的生物标志物)预测命名障碍,和是否淀粉样蛋白-β(Aβ)沉积(AD的病理特征)有助于这一预测。 20-9例AD患者均联合对β载荷和局部脑葡萄糖代谢的评估[11C] PIB和[18F] FDG PET检查。一个先验的定义感兴趣区域进行区域宠物左前颞叶分析。在线性逐步回归分析,对左前颞叶葡萄糖代谢是命名成绩的唯一有意义的预测因素,独立于性别、年龄、教育。无论是局部还是全部范围内的Aβ负荷没有给出预测。 左ATL葡萄糖代谢预测了AD命名障碍。相反,Aββ沉积不能预测命名障碍 。
关键词: 阿尔茨海默病,淀粉样蛋白,对抗命名,匹兹堡化合物,正电子发射断层扫描。
Current Alzheimer Research
Title:Left Anterior Temporal Glucose Metabolism and not Amyloid-beta Load Predicts Naming Impairment in Alzheimer’s Disease
Volume: 13 Issue: 6
Author(s): Lars Frings, Timo S. Spehl, Michael Hüll, Philipp T. Meyer
Affiliation:
关键词: 阿尔茨海默病,淀粉样蛋白,对抗命名,匹兹堡化合物,正电子发射断层扫描。
摘要: Naming impairment in Alzheimer’s disease dementia (AD) is associated with atrophy of the left anterior temporal lobe (ATL). We aimed to elucidate if regional cerebral glucose metabolism, as a biomarker of synaptic dysfunction and neurodegeneration, of the left ATL predicts naming impairment, and if amyloid-beta (Aβ) deposition, a pathological hallmark of AD, contributes to the prediction.
Twenty-nine patients with AD underwent combined [11C]PIB and [18F]FDG PET examinations for assessment of Aβ load and regional cerebral glucose metabolism. An a priori defined region of interest was used for regional PET analyses of the left ATL. In linear stepwise regression analyses, glucose metabolism of the left ATL was the only significant predictor of naming performance, independent of sex, age, and education. Neither regional nor global Aβ load contributed to the prediction.
Left ATL glucose metabolism predicts naming impairment in AD. By contrast, Aβ deposition does not predict naming impairment.
Export Options
About this article
Cite this article as:
Lars Frings, Timo S. Spehl, Michael Hüll, Philipp T. Meyer , Left Anterior Temporal Glucose Metabolism and not Amyloid-beta Load Predicts Naming Impairment in Alzheimer’s Disease, Current Alzheimer Research 2016; 13 (6) . https://dx.doi.org/10.2174/1567205013666160322141955
DOI https://dx.doi.org/10.2174/1567205013666160322141955 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Humanin: A Possible Linkage Between Alzheimer’s Disease and Type 2 Diabetes
CNS & Neurological Disorders - Drug Targets RAGE Signaling in Cell Adhesion and Inflammation
Current Pediatric Reviews MicroRNAs in Atrial Fibrillation
Current Medicinal Chemistry Patent Annotations
Recent Patents on CNS Drug Discovery (Discontinued) Gastrin-Releasing Peptide Receptor as a Molecular Target for Psychiatric and Neurological Disorders
CNS & Neurological Disorders - Drug Targets Bilateral Interrelationship of Diabetes and Periodontium
Current Diabetes Reviews LPS-induced Murine Neuroinflammation Model: Main Features and Suitability for Pre-clinical Assessment of Nutraceuticals
Current Neuropharmacology Implications of Parkinson’s Disease Pathophysiology for the Development of Cell Replacement Strategies and Drug Discovery in Neurodegenerative Diseases
CNS & Neurological Disorders - Drug Targets Occupational Complexity and Leisure Activities in Cognitive Aging
Current Psychopharmacology Transport Mechanisms at the Blood-Cerebrospinal-Fluid Barrier: Role of Megalin (LRP2)
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Epigallocatechin-3-gallate(EGCG): Mechanisms and the Combined Applications
Combinatorial Chemistry & High Throughput Screening Review of Theoretical Studies for Prediction of Neurodegenerative Inhibitors
Mini-Reviews in Medicinal Chemistry HIV-1-Associated Dementia During HAART Therapy
Recent Patents on CNS Drug Discovery (Discontinued) Predicted fold for the ABri Amyloid Subunit: A Model for Amyloidogenesis in Familial British Dementia.
Protein & Peptide Letters A New Regulatory Road-Map for Alzheimer’s Disease Drug Development
Current Alzheimer Research The Effect of First-in-Class Small Molecule RhoA Inhibitor, HL07, on the Phenylephrine-induced Artery Contraction
Current Pharmaceutical Design Familial Hypercholesterolemia: Update and Review
Endocrine, Metabolic & Immune Disorders - Drug Targets Phosphodiesterase Inhibitors as Potential Cognition Enhancing Agents
Current Topics in Medicinal Chemistry Vaccine Development for Alzheimers Disease
Current Pharmaceutical Design Athanasios Koukopoulos' Psychiatry: The Primacy of Mania and the Limits of Antidepressants
Current Neuropharmacology